Annual report pursuant to Section 13 and 15(d)

Shareholders' Deficit (Details) - Schedule of Warrant Activities

v3.24.1
Shareholders' Deficit (Details) - Schedule of Warrant Activities - Warrant [Member] - $ / shares
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2023
Dec. 31, 2022
Shareholders' Deficit (Details) - Schedule of Warrant Activities [Line Items]      
Number of Options, Balance Outstanding, Beginning (in Shares) 17,500,000    
Weighted Average Exercise Price, Balance Outstanding, Beginning $ 0.05    
Weighted Average Remaining Contractual Term (Years), Balance Outstanding, Beginning 4 years 8 months 1 day    
Aggregate Intrinsic Value, Balance Outstanding, Beginning    
Warrant [Member]      
Shareholders' Deficit (Details) - Schedule of Warrant Activities [Line Items]      
Number of Options, Balance Outstanding, Beginning (in Shares)   34,000,000  
Weighted Average Exercise Price, Balance Outstanding, Beginning   $ 0.011  
Aggregate Intrinsic Value, Balance Outstanding, Beginning    
Number of Options, Granted (in Shares)   33,000,000
Weighted Average Exercise Price, Granted   $ 0.025
Weighted Average Remaining Contractual Term (Years), Granted  
Aggregate Intrinsic Value, Granted  
Number of Options, Cancelled (in Shares)     (16,500,000)
Weighted Average Exercise Price, Cancelled     $ (0.05)
Weighted Average Remaining Contractual Term (Years), Cancelled    
Aggregate Intrinsic Value, Cancelled    
Number of Options, Balance Outstanding, Ending (in Shares)   34,000,000 34,000,000
Weighted Average Exercise Price, Balance Outstanding, Ending   $ 0.011 $ 0.011
Weighted Average Remaining Contractual Term (Years), Balance Outstanding, Ending   2 years 8 months 23 days 3 years 8 months 23 days
Aggregate Intrinsic Value, Balance Outstanding, Ending  
Number of Options, Exercisable (in Shares)   34,000,000  
Weighted Average Exercise Price, Exercisable   $ 0.011  
Weighted Average Remaining Contractual Term (Years), Exercisable   2 years 8 months 23 days  
Aggregate Intrinsic Value, Exercisable